Next Step For FDA's 'Case For Quality'? 8 New Guidance Docs
This article was originally published in The Gray Sheet
Executive Summary
Device manufacturers and FDA investigators reported generally positive experiences with FDA’s "critical-to-quality" inspection pilot, but the agency has decided to shift the focus to producing eight new guidance documents to better suit the project’s mission.
You may also be interested in...
At The Intersection Of Quality And Metrics: What's Ahead In FDA’s Effort To More Objectively Measure Quality
Quality metrics are being developed by the US FDA to not only determine which medical device facilities to inspect next, but to also raise firms' overall approach to quality above baseline. In-process metrics work by the Medical Device Innovation Consortium will be used as the agency comes up with its own robust set of measurements. Meanwhile, FDA is gearing up for a new pilot program targeting 10-20 device manufacturers that will submit quality data to the agency; MDIC explains how to calculate its three quality metrics; and quality officials from Baxter, J&J and Stryker weigh in.
Pandemic Response In US Consumer Health Market: OTC Pain Relief And Cough/Cold Purchases
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
venBio Raises $394m To Fund Biopharmas Through Human Proof-Of-Concept
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: